Department of Hematology

Hadassah University Hospital

Ein Karem, Jerusalem

Dr. Moshe Levin was born in New York, USA and studied Medicine at New York University.

By 1980 he completed his Internal Medicine training, Hematology and Oncology training at the same university. 

From 1986 to 2002 he was Chief of Oncology-Hematology department in Metropolitan Hospital center in NY where he was a member of numerous committees and active in educational activities as well as research. 

He was awarded prizes for the quality of his teaching in the years 1995 and 1997. 

Dr. Levin made aliya in 2002 and since then he is the head of the Hematology Service in Hadassah Mt. Scopus where he is implementing his vast experience both clinically and academically.

He participates actively in teaching residents and medical students and is an integral member of our Hematology Department. 

List of Publications

1. Franklin, E.C., Pras, M., Levin, M., and Frangione, B.: The partial Amino Acid Sequence of the Major Low Molecular Weight Components of Two Human Amyloid Fibrils. FEBS Lett. 22: 121-123, 1972.

2. Levin, M., Franklin, E.C., Frangione, B., and Pras, M.: The Amino Acid Sequence of a Major Non-immunoglobulin Component of Some Amyloid Fibrils. J. Clin. Invest. 51: 2773-2776, 1972.

3. Levin, M., Pras, M., and Franklin, E.C.:  Studies of the Major Non-immunoglobulin Protein of Amyloid. J. Exp. Med. 138: 373,1973.

4. Franklin, E.C., Levin, M., and Pras, M.:  Studies of the Non-immunoglobulin Component of Amyloid. Adv. Biosciences 12: 324, 1973.  Presented at the Schering Symposium of Immunopathology, Cavtat, Yugoslavia, May 28-June 1, 1973.

5. Franklin, E.C., Levin, M., Frangione, B., and Pras, M.:

A Non-immunoglobulin Component of Amyloid. In “Protides of the Biological Fluids” (J. Peeters, ed.), 1972.

6. Levin, M., Silber, R., Israel, M., Goldfeder, A., Khetarpal, V.H., and Potmesil, M.: DNA Non-binding Derivatives of Adriamycin Cause Protein-associated DNA- Protein Crosslinks in L1210 Cells. Canc. Res. 41: 1006- 1010, 1981.

7. Potmesil, M., Levin, M., Goldfeder, A., and Silber, R.: Adriamycin Damage: In Vivo Repair by Lymphoma Cells. J. Natl. Canc. Inst. 67: 1259-1263,  1981.

8. Spiegel, R.J., Blum, R.H., Levin, M., Pinto, C.A., Wernz, J.C., Speyer, J.L., Hoffman, K.S., and Muggia, F.M.: Phase I Clinical Trial of 9,10-Anthracene Dicarboxaldehyde (Bisantrene) Administered in a 5-day Schedule. Canc. Res. 42: 354-358. 1982.

9. Farber, C., Levin, M., Morgano, L., Liebes, L., Potmesil, M., and Silber, R.: Detection of DNA Damage in Normal and CLL Lymphocytes Using DNA Alkaline Elution. Blood 58: 426, 1981.

10. Potmesil, M., Levin, M., Traganos, T., Darzynkiewicz, Z., Goldfeder, A., and Silber, R.: In Vivo Effects of Adriamycin on N-Trifluoroacetyladriamycin-14-valerate on a Mouse Lymphoma. Europ. J. Canc. 19: 109, 1983.

11. Potmesil, M., Kirschenbaum, S., Israel, M., Levin, M., Khetarpal, V.K., and Silber, R: Relationship of Adriamycin Concentrations to the DNA Lesions Induced in Hypoxic and Euoxic L1210 Cells. Canc. Res. 43: 3528- 3533, 1983.

12. Levin, M., Bhatt, H., Forlenza, T., Farber, C., Penziner, A., Potmesil, M., and Silber, R.:  Damage and Repair of Chronic Lymphocytic Leukemia (CLL) Lymphocyte DNA Following Exposure to Radiation and/or Chlorambucil. Blood 6: 551, 1982.

13. Cumps, E., Bowen, J., Harris, M., Roses, D., Golomb, F., Valentine, F., Muggia, F., and Levin, M.,:  Human tumor clonogenic assay:  Chemosensitivity Testing in Soft Agar and Clinical Correlation in Malignant Melanoma. Clin. Res. 31: 405a, 1983.

14. Bottino, J.C., Green, M.D., Speyer, J.L., Levin, M., Nidus. B.D., Muggia, F.M.:  Repeated Femoral Vein Cannulation for Prolonged Chemotherapy Infusions. Proc. AM. Soc. Clin. Onc. 2: C-373, 1983.

15. Levin, M., Pandya, K., Khandekar, J., Horton, J., Glick, J., Bennett, J., Muggia, F., Falkson, G., and Silber, R.:  ECOG Trials of Mitoxantrone (DHAD) in Advanced Breast Cancer. Proc. Am. Soc. Clin. Onc. 2: C-397, 1983.

16. Pietronigro, D., Levin, M., Hovsepian, M., Demopoulos, H., and Silber, R.:  Tetrazolium salts (TS) stimulate adriamycin (ADR) Toxicity in L1210 Cells. Proc. Am. Assoc. Can. Res. 24: 1010, 1983.

17. Potmesil, M., Kirschenbaum, S., Israel, M., Levin, M., and Silber, R.: Dual Mechanism of Adriamycin (ADR)-DNA Interaction: Free-Radical Damage May Occur Only at High Drug Level. Proc. Am. Assoc. Can. Res. 24: 1011, 1983.

18. Spiegel, R.J. Nodar, R., and Levin, M.: Enhanced Adriamycin Cytotoxicity in L1210 Cells Following Lipid Modulation. Proc. Am. Assoc. Can. Res. 24: 1012, 1983.

19. Nidus, B.D., Speyer, J.L., Bottino, J., Green, M., Levin, M., and Muggia, F.M.: Repeated Femoral Vein Cannulation for Administration of Chemotherapeutic Agents. Canc. Treat. Repts. 67: 185-186, 1983.

20. Muggia, F.M., Spiegel, R.J., Gams, R.A., Levin, M., Cumps, E., and Ostroy, F.: Clinical Development of Bisantrene: A Novel Anthrancene Derivative. In: New Anticancer Drugs: Mitoxantrone and Bisantrene, M. Rozencweig et al. (eds.). Raven Press, NY, 1983. pp. 175-182.

21. Levin, M., Pandya, K.J., Khandekar, J.D., Horton, J., Glick, J.H., Bennett, J.M., Muggia, F.M., Falkson, G.: A Phase II Study of Mitoxantrone in Advanced Breast Cancer: An Eastern Cooperative Oncology Group Pilot Study. Canc Treat. Repts. 68: 1511-1512, 1984.

22. Bystryn, J-C., Levin, M., Bernstein, P., Speyer, J., and Walsh, D.:  Immunogenicity of a Polyvalent Melanoma Tumor Antigen Vaccine in Man. Amer. Assoc. Clin. Res. 907, 1984.

23. Bystryn, J-C., Levin, M., Speyer, J., Harris, M., Roses, D., and Bernstein, P. Phase I Trial of Specific Immunotherapy of Melanoma with a Polyvalent Melanoma Antigen Vaccine. Clin. Res. 32: 574a, 1984.

24. Hochster, H., Levin, M., Speyer, J., Dunleavey, S., Harris, M., Roses, D., Golomb, F., and Muggia, F. Bolus DTIC and actinomycin D in advanced malignant melanoma. Canc. Treat. Repts. 69: 39-42, 1985.

25. Hawkins, M.J., Levin, M., Borden, E.C.: An Eastern Cooperative Oncology Group Phase I-II Pilot Study of Polyriboinosinic-Polyribocytidylic Acid Poly-L-lysine Complex in Patients with Metastatic Malignant Melanoma. J. Biol. Resp. Modif. 4: 664-668, 1985.

26. Rao, S.X., Ramaswamy, G., Levin, M., McCravey, J.W.: Fatal Acute Respiratory Failure After Vinblastine- Mitomycin Therapy in Lung Carcinoma.  Arch Intern. Med. 145: 1905-1907, 1985.

27. Lin, R.Y., Levin, M., Nygren, E.N., Norman, A., Lorenzana, F.G.: Assessment of Platelet Antibody by Flow Cytometric and ELISA Techniques: A comparison Study. J. Lab. and Clin. Med. 116: 479-486, 1990.

28. Brady, J.O., Levin, M., Simon, K., Ahmed, T.: Simultaneous Ocurrence of Chronic Myelogenous Leukemia and Signet-Ringed Adenocarcinoma of the Rectum.  Acta Haematol. 91: 26-27, 1994.

29. Alfonso, C.A., Cohen, M.A.A., Levin, M., et. al.: Sexual Dysfunction in Cancer Patients: A Collaborative Psycho-Oncology Study. Abstract 36: 165 1995.  Psychosomatics.

30. Levin, M.: Advances in Pain Management: Transdermal Fentanyl for Clinical Use. Primary Care & Cancer, 15: 18-21, 1995.

31. Levin, M., Simon, K., Abraham, N., et. al.: Sexual Dysfunction Among Cancer Patients From An Inner City Hospital.  Proc. Amer. Soc. Clin. Onco. 14: 1659, 1995.

32. Sy, M., Gondal, N., Levin, M., Simon, K., Abraham, N., & Nowakowski, J.:The Comparative Utility of Bone Marrow Examination and Blood Cultures in Disseminated Mycobacterium Avium Intracellulare in  Human Immunodeficiency Virus Sero-positive Patients.  Proc. Amer. Soc. Hema. 1995.

33. Alfonso, C.A., Cohen, M.A., Levin, M., et. al.: Sexual Dysfunction in cancer Patients: A Collaborative Psychooncology Project Int. J. ment. Health. 26: 90-98, 1997.         

34. Levin, M., Potter, G.K., & Shah, M.S.: Review and Consideration of Coagulopathies. Clinics in Podiatric Medicine and Surgery. 15: 499-512, 1998.

35. Cutler, K., Chu, P., Levin, M., et. al.:  Pedunculated Malignant Melanoma. Dermatol. Surg. 8: 812-4, 2000

36. Colon Cancer Screening.  Manuscript in preparation

37. Simultaneous Malt Lymphoma of Stomach and Lungs.  Manuscript in preparation

38. Gennarelli, M.D., Jandorf, L., Milosevic, M., Weeks, M,. Levin, M., Butts, G., Redd, W., Itzkowitz, S.H. Barriers to Colorectal Cancer (CRC) Screening in minority communities: Practice Patterns of Primary Care Physicians. Gastroenterology 120:3066, 2001.

39. Stepensky, P., Prus, D., Libster, D., Amir, G., Weintraub, M., Levin, M., Urieli-Shoval, S. Expression of Serum Amyloid A, a Major Acute Phase Protein, in Human Hodgkin and Non-Hodgkin Lymphoma Tissues. Blood 102, 2003. (Abstract, in Press)

40. Urieli-Shoval, S., Libenson-Naor, R., Levin, M. Expression of Serum Amyloid A, a Major Acute Phase Protein, in Human Leukemias. Blood 102, 2003. (Abstract, in Press)